ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,680Medicare Part D Prescriptions Filled, Including Refills

Rank: 184 out of 676

$581K Total Retail Price of All Prescriptions

Rank: 186 out of 676

619 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 619 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

17% of this provider’s 619 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 8,451 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
LISINOPRIL 516 419 1 5
OMEPRAZOLE 424 295 2 2
SIMVASTATIN 394 298 3 6
AMLODIPINE BESYLATE 359 332 4 3
FUROSEMIDE 355 249 5 4
HYDROCODONE-ACETAMINOPHEN 346 202 S3 6 1
LEVOTHYROXINE SODIUM 276 197 7 7
METFORMIN HCL 261 170 8 8
CARVEDILOL 254 203 9 15
GABAPENTIN 231 163 10 10
POTASSIUM CHLORIDE 230 178 11 9
HYDROCHLOROTHIAZIDE 220 160 12 12
PRAVASTATIN SODIUM 215 129 13 11
METOPROLOL SUCCINATE 194 168 14 14
SERTRALINE HCL 173 131 15 26
WARFARIN SODIUM 172 154 16 18
ZOLPIDEM TARTRATE 167 88 17 21
MELOXICAM 154 100 18 13
PREDNISONE 150 115 19 53
DIOVAN 134 109 20 37
DONEPEZIL HCL 129 129 21 24
AMITRIPTYLINE HCL 127 91 R 22 46
NEXIUM 125 74 23 23
RANITIDINE HCL 119 84 24 27
CIPROFLOXACIN HCL 107 70 25 45
CRESTOR 104 83 26 29
CITALOPRAM HBR 104 75 26 17
AZITHROMYCIN 100 67 28 39
ATORVASTATIN CALCIUM 97 94 29 20
CLOPIDOGREL 96 69 30 28
GLIPIZIDE ER 89 59 31 103
LOSARTAN POTASSIUM 87 73 32 34
ADVAIR DISKUS 84 51 33 87
TRAMADOL HCL 83 42 34 19
LEVOFLOXACIN 77 51 35 91
PANTOPRAZOLE SODIUM 77 42 35 42
METOPROLOL TARTRATE 75 67 37 22
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 46 38 74
LOVASTATIN 72 62 39 33
DIOVAN HCT 70 65 40 41
CYMBALTA 69 33 41 47
AGGRENOX 66 52 42 147
JANUMET 63 28 43 167
TAMSULOSIN HCL 61 51 44 38
QUETIAPINE FUMARATE 60 60 45 72
GLIPIZIDE 59 39 46 81
CLONIDINE HCL 59 47 46 32
LYRICA 56 27 48 57
RISPERIDONE 56 54 48 69
GLIMEPIRIDE 55 35 50 30
PROAIR HFA 54 30 51 79
LISINOPRIL-HYDROCHLOROTHIAZIDE 52 43 52 16
PAROXETINE HCL 52 44 52 65
ATENOLOL 52 41 52 25
SINGULAIR 50 26 55 80
PLAVIX 50 38 55 40
LIPITOR 50 50 55 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 29, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.